Pasithea Therapeutics Cor...

NASDAQ: KTTA · Real-Time Price · USD
0.71
0.01 (1.04%)
At close: Aug 15, 2025, 3:59 PM
0.71
-0.49%
After-hours: Aug 15, 2025, 07:51 PM EDT

Pasithea Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a 976.31K n/a n/a n/a 240.71K 218.61K 13.58K 13.66K 15.06K n/a n/a n/a
Cost of Revenue
161.71K 162.26K n/a 162.26K 162.26K 162.22K 162.26K 163.22K 162.68K 1.31K 86.47K 15.1K 12.94K 17.27K n/a n/a n/a
Gross Profit
-161.71K n/a n/a -162.26K -162.26K 814.09K -162.26K -163.22K -162.68K 239.4K 132.14K -1.52K 721.00 -2.21K n/a n/a n/a
Operating Income
-3.68M -3.26M -3M -3.95M -4.04M -5.15M -3.79M -3.83M -3.21M -5.08M -3.86M -3.08M -2.4M -1.96M -1.27M -727.95K -549.61K
Interest Income
47.24K 80.48K 75.08K 114.41K 153.22K 172.82K 131.74K 117.19K n/a 102.00 n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-3.56M -3.18M -3M -3.87M -3.86M -5.03M -3.61M -3.6M -3.27M -5.12M -4.19M -2.66M -1.57M 630.14K -1.53M -727.95K -549.61K
Net Income
-3.56M -3.18M -3M -3.87M -3.86M -5.05M -3.61M -3.76M -275.13M -3.9M -4.59M -1.81M 41.35K 630.12K -1.53M -727.95K -549.61K
Selling & General & Admin
1.79M 1.75M 1.42M 1.59M 2.13M 1.64M 2.16M 1.8M 2.12M 3.94M 2.58M 3.08M 2.41M 1.95M 1.27M 727.95K 549.61K
Research & Development
1.73M 1.51M 1.58M 2.36M 1.75M 3.35M 1.62M 2.03M 1.1M 1.39M 1.28M n/a n/a n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a -277 n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
3.52M 3.1M 3M 3.95M 3.88M 4.99M 3.79M 3.83M 3.21M 5.32M 3.86M 3.08M 2.41M 1.95M 1.27M 727.95K 549.61K
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a 6.39K 102.00 n/a n/a n/a n/a 508.00 n/a n/a
Selling & Marketing Expenses
n/a -3.55M n/a n/a -2.29B -7.88B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.68M 3.26M 3M 3.95M 4.04M 5.15M 3.79M 3.83M 3.21M 5.32M 3.86M 3.09M 2.42M 1.97M 1.27M 727.95K 549.61K
Income Tax Expense
n/a -2 n/a n/a 2.00 16.89K n/a n/a 271.87M -1.22M n/a -843.4K -1.62M 20.00 n/a n/a n/a
Shares Outstanding (Basic)
1.1M 1.1M 1.04M 1.04M 1.04M 1.04M 1.26M 1.31M 1.3M 1.3M 1.33M 1.17M 1.15M 1.15M 660.42K 688.92K 688.92K
Shares Outstanding (Diluted)
1.1M 1.1M 1.04M 1.04M 1.04M 1.04M 1.26M 1.31M 1.3M 1.3M 1.33M 1.17M 1.15M 1.15M 660.42K 688.92K 688.92K
EPS (Basic)
-3.25 -2.9 -2.87 -3.71 -3.7 -4.85 -2.87 -2.88 -211.05 -3 -3.45 -2.27 -1.37 0.55 -2.31 -1.06 -0.8
EPS (Diluted)
-3.25 -2.9 -2.87 -3.71 -3.7 -4.85 -2.87 -2.88 -211.05 -3 -3.45 -2.27 -1.37 0.55 -2.31 -1.06 -0.8
EBITDA
-3.4M -3.1M -2.84M -3.78M -3.88M -4.99M -3.63M -3.67M -3.1M -4.04M -3.86M -3.08M -2.4M 2.6M -1.27M -727.95K -549.61K
EBIT
-3.56M -3.26M -3M -3.95M -4.04M -5.15M -3.79M -3.83M -3.26M -4.2M -3.86M -2.61M -1.29M 630.14K -1.27M -727.95K -549.61K
Depreciation & Amortization
161.71K 162.26K 162.26K 162.26K 162.26K 162.22K 162.26K 163.22K 162.68K 74.21K n/a -410.91K -780.28K 2.59M 54K 55.81K 55.21K